Experiment 1140536

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

TUNICAMYCIN

Alerts

A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationMORIN,MJ: BERNACKI,RJ:. (1983). BIOCHEMICAL EFFECTS AND THERAPEUTIC POTENTIAL OF TUNICAMYCIN IN MURINE L 1210 LEUKEMIA.. 43(4)
Amount utilized
Compound isolated
DiseaseDOSING ON DAYS 1-3 WITH 24-HR INFUSION OF D-MANNOSE ON DAY-1.
Dose amount0.5 MG
Number10
Qualitative resultINACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE